Post-prenylation-processing enzymes as new targets in oncogenesis.

Nat Rev Cancer

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Published: May 2005

RAS and many other oncogenic proteins undergo a complex series of post-translational modifications that are initiated by the addition of an isoprenoid lipid through a process known as prenylation. Following prenylation, these proteins usually undergo endoproteolytic processing by the RCE1 protease and then carboxyl methylation by a unique methyltransferase known as isoprenylcysteine carboxyl methyltransferase (ICMT). Although inhibitors that have been designed to target the prenylation step are now in advanced-stage clinical trials, their utility and efficacy seem to be limited. Recent findings, however, indicate that the inhibition of these post-prenylation-processing steps--particularly that of ICMT-catalysed methylation--might provide a better approach to the control of cancer-cell proliferation.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc1612DOI Listing

Publication Analysis

Top Keywords

proteins undergo
8
post-prenylation-processing enzymes
4
enzymes targets
4
targets oncogenesis
4
oncogenesis ras
4
ras oncogenic
4
oncogenic proteins
4
undergo complex
4
complex series
4
series post-translational
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!